At a glance
Strengthening STD Prevention and Control for Health Departments, or STD PCHD, is CDC's flagship funding to prevent and control sexually transmitted infections (STIs). This page overviews details about the funding.
What is STD PCHD?
STD PCHD is a cooperative agreement for health departments to implement and strengthen STI prevention and control programs. Its purpose is to prevent and control chlamydia, gonorrhea, and syphilis. More information is available in the STD PCHD infographic.
For questions about the funding, please email std_pchd@cdc.gov.
What does the funding support?
State and city health departments use funding to carry out the following priority strategies and activities:
- Monitor STI cases and trends
- Provide on-the-ground prevention support
- Promote testing and treatment best practices
- Increase STI prevention knowledge
- Turn data into action
An STI Prevention Success Story
Preventing Congenital Syphilis in the US
Learn about the nine CDC-funded jurisdictions that made great strides in establishing and activating systems to help identify and prevent congenital syphilis in their communities.
Check out the full suite of STI prevention success stories.
What else should people know about STD PCHD?
STD PCHD supports strategies and activities to
- Eliminate congenital syphilis
- Prevent drug-resistant gonorrhea
- Reduce primary and secondary syphilis
- Prevent STI-related pelvic inflammatory disease, ectopic pregnancy, and infertility
- Address STI-related outbreaks
- Reduce STI-related health disparities
The funding focuses on these priority populations
- Adolescents and young adults
- Gay, bisexual, and other men who have sex with men
- Pregnant people
It funds these recipients
Award recipients include state, local and territorial health departments or their Bona Fide Agents. This includes the 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Also included are the local (county or city) health departments serving the following metropolitan areas: Baltimore, MD; Chicago, IL; Los Angeles, CA; Philadelphia, PA; New York City, NY; and San Francisco, CA.